Skip to content

AZ.PHARMABEL

Active
Private limited company (pre-2019)founded 201313 yrs activeRichard Vandeveldestraat 57A, 1030 Schaarbeek, BelgiumKBO/BCE: BE 0508.863.780
Summary

AZ.PHARMABEL has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €100,741 and a net result of €8,418. Equity is growing by ~54.4% per year across the filed fiscal years. Its solvency ranks better than 32% of 4652 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€966,662turnover 2025
Equity
€100,741
Profit
€8,418
Financial health
82 Excellent Checked score 2025
Bankruptcy chance 12 m
0.5%
Structure
Accounts filed 18 d late0 of 1 deed read
Why 82- Latest accounts 19 days late; 1 of the last 3 late- Sector Retail trade (NACE 47)- Equity €100,741 (21.0% of total assets)+ Founded in 2013Show the evidence

Checked score

Score 2025
82 / 100
Excellent
Probability in this band: under 0.55%
Better than 45% of its sector peers (NACE 47, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Average
Solvency 46+1
equity 21.0% of total assets
Liquidity 51+6
short-term debt 57.8% · cash 24.5%
Profitability 57-14
return on assets 1.8%
Bankruptcy probability, 12 months
0.5% Very low
0%0.5%1.5%4%10%≥ 25%

About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.7% (39,919 companies)
Last 24 months 11-2024: 0.6% 12-2024: 0.5%▼ -3.0% vs 11-2024 01-2025: 0.7%▲ +19.2% vs 12-2024 02-2025: 1.0%▲ +46.1% vs 01-2025 03-2025: 1.1%▲ +20.1% vs 02-2025highest value 04-2025: 0.6%▼ -47.6% vs 03-2025 05-2025: 0.6%● 0.0% vs 04-2025 06-2025: 0.6%● 0.0% vs 05-2025 07-2025: 0.6%● 0.0% vs 06-2025 08-2025: 0.6%▲ +0.7% vs 07-2025 09-2025: 0.6%▼ -0.7% vs 08-2025 10-2025: 0.6%● 0.0% vs 09-2025 11-2025: 0.6%▼ -0.2% vs 10-2025 12-2025: 0.6%▼ -3.8% vs 11-2025 01-2026: 0.6%▲ +8.7% vs 12-2025 02-2026: 0.9%▲ +43.4% vs 01-2026 03-2026: 0.5%▼ -45.9% vs 02-2026lowest value 04-2026: 0.5%● 0.0% vs 03-2026lowest value 05-2026: 0.5%● 0.0% vs 04-2026lowest value 06-2026: 0.5%● 0.0% vs 05-2026lowest value 07-2026: 0.5%● 0.0% vs 06-2026lowest value 08-2026: 0.5%▲ +0.6% vs 07-2026 09-2026: 0.5%▼ -0.6% vs 08-2026lowest value 10-2026: 0.5%● 0.0% vs 09-2026lowest value
  • Founded in 2013 lowers the probability for this profile
  • Latest accounts 19 days late; 1 of the last 3 late raises the probability
  • Sector Retail trade (NACE 47) raises the probability
  • Equity €100,741 (21.0% of total assets) raises the probability
Credit up to €8,000 at 30 days acceptable
Liquidity tight (current ratio 1.02 against 0.79 in 2024; short-term debt: 57.8% and cash: 24.5% of total assets), and 79% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, micro). Better than this share of them on solvency 37%, liquidity 55%, profitability 40%, growth against the median 51%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Founded in 2013
In the bankruptcy model this factor lowers the probability for this profile.
KBO
raises risk · Latest accounts 19 days late; 1 of the last 3 late
In the bankruptcy model this factor raises the probability.
NBB · filings
raises risk · Sector Retail trade (NACE 47)
In the bankruptcy model this factor raises the probability.
KBO
raises risk · Equity €100,741 (21.0% of total assets)
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
neutral · Filed after the deadline
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 18-02-2026, 18 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
18 d late
2024
52 d late
2023
8 d late
2022
10 d late
2021
7 d late
2020
8 d late
2019
16 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 12 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today. Usually files around 10 February (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
30-06-2026 close03-10-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · full…
  2. Equity above €100,000Eq €100,741 ▲9.1%
  3. Annual accounts filedfiscal year 2024 · full…

Key points

  • Positive: 7 profitable years in a rowprofit 2025: €8,418 7 years View
  • Turnover 20255 fiscal years filed €966,662 View
  • Active since 2013founded 03-01-2013 13 years View

By topic

Financials

Fiscal year
2025
Turnover
€966,662
Profit
€8,418
Solvency
21.0%
Turnover▼ 1.7%
Net result
20212025
Go to Financials

Timeline

Events
13
Since
2017
Next accounts
by 31-01-2027
  1. 18-02-2026Annual accounts filed
  2. 30-06-2025Equity above €100,000
  3. 24-03-2025Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company (pre-2019)
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
03-01-2013
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.